不眠症治療の世界市場レポート 2025年

不眠症治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.7％で40億1,000万米ドルに成長します。予測期間中の成長は、AIを活用した睡眠モニタリングの進歩、個別化医療に対する需要の高まり、睡眠障害を抱える高齢者人口の増加、メンタルヘルスに対する意識の高まり、新規不眠症治療のパイプラインの拡大などに起因すると考えられます。予測期間における主な動向としては、不眠症治療におけるデジタル治療薬の統合、非薬物療法への嗜好の高まり、ウェアラブル睡眠トラッカーの採用拡大、次世代睡眠薬の開発、睡眠障害管理における遠隔医療の成長などが挙げられます。

ストレスレベルの上昇とライフスタイルの変化は、不眠症治療市場の成長を促進すると予想されます。これらの要因とは、感情的な緊張や睡眠パターンの乱れの原因となる、日常生活における心理的・行動的な変化を指します。現代生活における絶え間ないデジタル接続は、仕事と生活の境界線を侵食し、適切な精神的休息の時間を制限し、ストレスレベルを悪化させます。不眠症治療は、健康的な睡眠パターンを回復し、睡眠に関連する不安を和らげ、現代生活のプレッシャーの中で精神的な幸福をサポートする、科学的裏付けのある効果的な治療ソリューションを提供します。例えば、2024年5月、米国精神医学会（APA）は、米国の成人のうち不安を感じる人の割合が2022年の32％から2024年には43％に上昇したと報告しました。不安やストレスのレベルが上昇するにつれ、不眠症治療への需要が高まり、市場の拡大をさらに後押ししています。

不眠症治療市場の主要企業は、デュアルオレキシン受容体拮抗薬（DORA）などの先進治療薬の開発に注力しており、副作用が少なく、安全性プロファイルが改善された標的治療の選択肢を提供しています。DORAは、覚醒促進に関与する脳内のオレキシン-1およびオレキシン-2受容体の両方を阻害する薬剤です。これらの受容体を阻害することで、DORAは睡眠を誘発し、特に慢性不眠症の治療に有効です。2023年6月、イドルシア・ファーマシューティカルズ社は、慢性不眠症治療としてファースト・イン・クラスのDORAであるQUVIVIQ（ダリドレキサント）を発売しました。この治療薬は、自然な睡眠構造を阻害することなく夜間の覚醒を軽減し、患者に入眠、維持、日中機能の改善をもたらします。QUVIVIQの承認は、不眠症治療における重要なブレークスルーであり、長期的で習慣性のない治療オプションに対するニーズに応えるものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の不眠症治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の不眠症治療市場：成長率分析
• 世界の不眠症治療市場の実績：規模と成長、2019年～2024年
• 世界の不眠症治療市場の予測：規模と成長、2024年～2029年、2034年
• 世界の不眠症治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の不眠症治療市場：治療タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 医薬品
• 医療機器
• 世界の不眠症治療市場：処方別、実績と予測、2019年～2024年、2024年～2029年、2034年
• タブレット
• カプセル
• 液体ソリューション
• パッチ
• 世界の不眠症治療市場：投与経路別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 経口
• 静脈内
• 経皮
• その他の投与経路
• 世界の不眠症治療市場：流通チャネル別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• クリニック
• ウェルネスセンター
• 世界の不眠症治療市場、医薬品の種類別のサブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• ベンゾジアゼピン
• 非ベンゾジアゼピン系
• 抗うつ薬
• オレキシン拮抗薬
• メラトニン拮抗薬
• その他の薬物
• 世界の不眠症治療市場、医療機器の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 認知行動療法デバイス（CBT-Iデバイス）
• 睡眠ポリグラフ装置
• 睡眠追跡デバイス
• 神経刺激装置
• 光療法装置

第7章 地域別・国別分析

• 世界の不眠症治療市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界の不眠症治療市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 不眠症治療市場：競合情勢
• 不眠症治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Eisai Co. Ltd.
• Sumitomo Pharma Co. Ltd.
• Aurobindo Pharma
• Astellas Pharma Inc.
• Acadia Pharmaceuticals Inc.
• Vanda Pharmaceuticals Inc.
• Idorsia Ltd
• Minerva Neurosciences
• Big Health
• Neurovalens
• Electromedical Products International Inc.
• Neurim Pharmaceuticals Ltd.
• Innovative Neurological Devices（IND）
• Blake Insomnia Therapeutics Inc.
• Cereve Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 不眠症治療市場2029年：新たな機会を提供する国
• 不眠症治療市場2029年：新たな機会を提供するセグメント
• 不眠症治療市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Insomnia therapeutics refer to treatments designed to manage and alleviate the symptoms of insomnia, a condition characterized by difficulty falling or staying asleep. These treatments include prescription medications, over-the-counter sleep aids, and non-pharmacological approaches such as cognitive behavioral therapy for insomnia (CBT-I).

The primary treatment types in insomnia therapeutics are drugs and medical devices. Drugs used in insomnia therapeutics are pharmacological agents specifically developed to treat sleep disorders by improving sleep initiation, maintenance, or overall sleep quality through mechanisms that regulate the sleep-wake cycle. These formulations include tablets, capsules, liquid solutions, and patches, and are administered through various routes such as oral, intravenous, transdermal, and others. They are distributed through multiple channels, including hospital pharmacies, retail pharmacies, online pharmacies, clinics, and wellness centers.

The insomnia therapeutics market research report is one of a series of new reports from The Business Research Company that provides insomnia therapeutics market statistics, including insomnia therapeutics industry global market size, regional shares, competitors with an insomnia therapeutics market share, detailed insomnia therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the insomnia therapeutics industry. This insomnia therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The insomnia therapeutics market size has grown strongly in recent years. It will grow from$3.03 billion in 2024 to $3.21 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth during the historic period can be attributed to the increasing prevalence of insomnia, greater awareness of sleep disorders, the rising adoption of cognitive behavioral therapy for insomnia (CBT-I), the expansion of pharmaceutical treatments, and the growing use of over-the-counter sleep aids.

The insomnia therapeutics market size is expected to see strong growth in the next few years. It will grow to$4.01 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth during the forecast period can be attributed to advancements in AI-driven sleep monitoring, increasing demand for personalized medicine, a growing geriatric population with sleep disorders, rising mental health awareness, and an expanding pipeline of novel insomnia drugs. Key trends in the forecast period include the integration of digital therapeutics in insomnia treatment, the rising preference for non-pharmacological therapies, the increasing adoption of wearable sleep trackers, the development of next-generation sleep medications, and the growth of telemedicine for sleep disorder management.

The rising stress levels and lifestyle changes are expected to drive the growth of the insomnia therapeutics market. These factors refer to the psychological and behavioral shifts in daily routines that contribute to emotional strain and disrupted sleep patterns. The constant digital connectivity in modern life erodes work-life boundaries, limiting time for proper mental rest and exacerbating stress levels. Insomnia therapeutics offer effective, science-backed treatment solutions that help restore healthy sleep patterns, alleviate sleep-related anxiety, and support mental well-being amid the pressures of modern life. For example, in May 2024, the American Psychiatric Association (APA) reported that the percentage of U.S. adults feeling more anxious rose from 32% in 2022 to 43% in 2024. As anxiety and stress levels climb, the demand for insomnia treatments is growing, further driving the market's expansion.

Leading companies in the insomnia therapeutics market are focusing on developing advanced therapies, such as dual orexin receptor antagonists (DORAs), to offer targeted treatment options with fewer side effects and improved safety profiles. DORAs are medications that block both orexin-1 and orexin-2 receptors in the brain, which are involved in promoting wakefulness. By inhibiting these receptors, DORAs help induce sleep and are particularly effective in treating chronic insomnia. In June 2023, Idorsia Pharmaceuticals Ltd. launched QUVIVIQ (daridorexant), a first-in-class DORA for the treatment of chronic insomnia disorder. This therapy reduces nighttime wakefulness without disrupting natural sleep architecture, offering patients improved sleep onset, maintenance, and daytime functioning. QUVIVIQ's approval marks a significant breakthrough in insomnia treatment, addressing the need for long-term, non-habit-forming therapeutic options.

In August 2022, ResMed Inc. acquired Mementor, a company providing digital health solutions for sleep disorders such as insomnia. This acquisition strengthens ResMed's position in the insomnia therapeutics market by integrating Mementor's evidence-based digital health app into its offerings. With the integration, ResMed aims to expand access to reimbursable, digital therapy solutions in Germany, advancing its digital sleep medicine strategy. Mementor's app offers a digital approach to insomnia treatment, providing users with personalized, therapeutic content that addresses the root causes of sleep disturbances. This acquisition enhances ResMed's ability to offer accessible and innovative insomnia treatment solutions.

Major players in the insomnia therapeutics market are Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Eisai Co. Ltd., Sumitomo Pharma Co. Ltd., Aurobindo Pharma, Astellas Pharma Inc., Acadia Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Idorsia Ltd, Minerva Neurosciences, Big Health, Neurovalens, Electromedical Products International Inc., Neurim Pharmaceuticals Ltd., Innovative Neurological Devices (IND), Blake Insomnia Therapeutics Inc., and Cereve Inc.

North America was the largest region in the insomnia therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in insomnia therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the insomnia therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The insomnia therapeutics market consists of sales of herbal sleep aids, wearable sleep devices, sleep-enhancing audio devices, aromatherapy products, smart mattresses, sleep masks with embedded technology, blue light-blocking glasses, and biofeedback devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Insomnia Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on insomnia therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for insomnia therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The insomnia therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Drugs; Medical Devices
• 2) By Formulation: Tablets; Capsules; Liquid Solutions; Patches
• 3) By Route Of Administration: Oral; Intravenous; Transdermal; Other Routes Of Administration
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Clinics; Wellness Centers
• Subsegments:
• 1) By Drugs: Benzodiazepines; Nonbenzodiazepines; Antidepressants; Orexin Antagonists; Melatonin Antagonists; Other Drugs
• 2) By Medical Devices: Cognitive Behavioral Therapy Devices (CBT-I Devices); Polysomnography Devices; Sleep Tracking Devices; Neurostimulation Devices; Light Therapy Devices
• Companies Mentioned: Pfizer Inc.; Sanofi S.A.; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Merck KGaA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Insomnia Therapeutics Market Characteristics

3. Insomnia Therapeutics Market Trends And Strategies

4. Insomnia Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Insomnia Therapeutics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Insomnia Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Insomnia Therapeutics Market Growth Rate Analysis
• 5.4. Global Insomnia Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Insomnia Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Insomnia Therapeutics Total Addressable Market (TAM)

6. Insomnia Therapeutics Market Segmentation

• 6.1. Global Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drugs
• Medical Devices
• 6.2. Global Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Liquid Solutions
• Patches
• 6.3. Global Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Transdermal
• Other Routes of Administration
• 6.4. Global Insomnia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Clinics
• Wellness Centers
• 6.5. Global Insomnia Therapeutics Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Benzodiazepines
• Nonbenzodiazepines
• Antidepressants
• Orexin Antagonists
• Melatonin Antagonists
• Other Drugs
• 6.6. Global Insomnia Therapeutics Market, Sub-Segmentation Of Medical Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cognitive Behavioral Therapy Devices (CBT-I Devices)
• Polysomnography Devices
• Sleep Tracking Devices
• Neurostimulation Devices
• Light Therapy Devices

7. Insomnia Therapeutics Market Regional And Country Analysis

• 7.1. Global Insomnia Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Insomnia Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Insomnia Therapeutics Market

• 8.1. Asia-Pacific Insomnia Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Insomnia Therapeutics Market

• 9.1. China Insomnia Therapeutics Market Overview
• 9.2. China Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Insomnia Therapeutics Market

• 10.1. India Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Insomnia Therapeutics Market

• 11.1. Japan Insomnia Therapeutics Market Overview
• 11.2. Japan Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Insomnia Therapeutics Market

• 12.1. Australia Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Insomnia Therapeutics Market

• 13.1. Indonesia Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Insomnia Therapeutics Market

• 14.1. South Korea Insomnia Therapeutics Market Overview
• 14.2. South Korea Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Insomnia Therapeutics Market

• 15.1. Western Europe Insomnia Therapeutics Market Overview
• 15.2. Western Europe Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Insomnia Therapeutics Market

• 16.1. UK Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Insomnia Therapeutics Market

• 17.1. Germany Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Insomnia Therapeutics Market

• 18.1. France Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Insomnia Therapeutics Market

• 19.1. Italy Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Insomnia Therapeutics Market

• 20.1. Spain Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Insomnia Therapeutics Market

• 21.1. Eastern Europe Insomnia Therapeutics Market Overview
• 21.2. Eastern Europe Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Insomnia Therapeutics Market

• 22.1. Russia Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Insomnia Therapeutics Market

• 23.1. North America Insomnia Therapeutics Market Overview
• 23.2. North America Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Insomnia Therapeutics Market

• 24.1. USA Insomnia Therapeutics Market Overview
• 24.2. USA Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Insomnia Therapeutics Market

• 25.1. Canada Insomnia Therapeutics Market Overview
• 25.2. Canada Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Insomnia Therapeutics Market

• 26.1. South America Insomnia Therapeutics Market Overview
• 26.2. South America Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Insomnia Therapeutics Market

• 27.1. Brazil Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Insomnia Therapeutics Market

• 28.1. Middle East Insomnia Therapeutics Market Overview
• 28.2. Middle East Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Insomnia Therapeutics Market

• 29.1. Africa Insomnia Therapeutics Market Overview
• 29.2. Africa Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Insomnia Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. Insomnia Therapeutics Market Competitive Landscape
• 30.2. Insomnia Therapeutics Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Insomnia Therapeutics Market Other Major And Innovative Companies

• 31.1. Eisai Co. Ltd.
• 31.2. Sumitomo Pharma Co. Ltd.
• 31.3. Aurobindo Pharma
• 31.4. Astellas Pharma Inc.
• 31.5. Acadia Pharmaceuticals Inc.
• 31.6. Vanda Pharmaceuticals Inc.
• 31.7. Idorsia Ltd
• 31.8. Minerva Neurosciences
• 31.9. Big Health
• 31.10. Neurovalens
• 31.11. Electromedical Products International Inc.
• 31.12. Neurim Pharmaceuticals Ltd.
• 31.13. Innovative Neurological Devices (IND)
• 31.14. Blake Insomnia Therapeutics Inc.
• 31.15. Cereve Inc.

32. Global Insomnia Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Insomnia Therapeutics Market

34. Recent Developments In The Insomnia Therapeutics Market

35. Insomnia Therapeutics Market High Potential Countries, Segments and Strategies

• 35.1 Insomnia Therapeutics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Insomnia Therapeutics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Insomnia Therapeutics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer